Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs2111829 | chr14:78197283 | T/C | 8.31E-5 | 132 | 45.83 | 39.38 | 18.07 | KM Plot |
| TGCT | rs2112789 | chr16:27807575 | T/G | 1.04E-5 | 133 | 46.53 | 33.55 | 17.27 | KM Plot |
| TGCT | rs2112920 | chr19:37955248 | C/G | 5.33E-13 | 128 | 45.47 | 34.7 | 17.1 | KM Plot |
| TGCT | rs2113078 | chr5:56087190 | C/T | 8.27E-6 | 134 | 69.48 | 41.27 | 43.97 | KM Plot |
| TGCT | rs2131588 | chr5:1835306 | C/T | 1.73E-10 | 131 | 41.33 | 51.67 | 19.5 | KM Plot |
| TGCT | rs2131589 | chr5:1835384 | T/C | 1.73E-10 | 131 | 41.33 | 51.67 | 19.5 | KM Plot |
| TGCT | rs2170988 | chr12:129290876 | A/C | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs2172530 | chr5:1835083 | A/G | 1.73E-10 | 131 | 41.33 | 51.67 | 19.5 | KM Plot |
| TGCT | rs2205259 | chr8:116908222 | G/A | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs2217076 | chr12:107053685 | C/T | 0.000103 | 134 | 48.87 | 38.2 | 28.8 | KM Plot |
| TGCT | rs2239661 | chr13:111591265 | G/A | 0 | 133 | 39.38 | 57.7 | 0.57 | KM Plot |
| TGCT | rs2268686 | chr6:42669108 | G/A | 4.75E-6 | 127 | 40.08 | 49.93 | 23.82 | KM Plot |
| TGCT | rs2268687 | chr6:42668932 | G/A | 4.75E-6 | 127 | 40.08 | 49.93 | 23.82 | KM Plot |
| TGCT | rs227917 | chr7:23646317 | C/A | 8.78E-5 | 132 | 53.65 | 36.23 | 50.45 | KM Plot |
| TGCT | rs227922 | chr7:23652034 | T/C | 0.000124 | 128 | 53.65 | 36.23 | 48.35 | KM Plot |